KRAS and colorectal cancer: In colorectal cancer, Lu/BCAM is overexpressed in clinical KRAS-mutant hepatic metastasis and the inhibition of its interaction with laminin α5 impaired adhesion of colorectal cancer cells to vascular endothelial cells, resulting in a reduction of metastatic growth [87].